Four takeaways from the latest round of federal CBD warning letters

Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Four takeaways from the latest round of federal CBD warning letters,” published on September 12, 2019.

A recent series of warning letters from the US Federal Trade Commission (FTC) served as a reminder that as CBD goes mainstream, federal agencies are monitoring the industry and will not hesitate to take enforcement action, especially when it comes to unsubstantiated product claims, including those made in testimonials. Emily noted that user testimonials and influencer posts on Instagram can land a company in hot water, so companies should have in place standardized processes and procedures for reviewing all product claims for regulatory compliance prior to publication, dissemination, or use

“This needs to be top of mind,” she said. “Your marketing team [and] your compliance team needs to be familiar with [and implement] FDA and FTC … guidelines.”

Read the full article here.


Continue Reading